Mutations in AML: prognostic and therapeutic implications.

Abstract excerpt

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the proliferation and aberrant differentiation of immature clonal myeloid cells. The prognosis of AML is variable, based on clinical features such as patient age, performance status, and comorbidities, as well as leukemia-specific genetic features including cytogenetics and molecular classification. The modern application of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to High-Throughput Nucleotide Sequencing
• Share to Leukemia, Myeloid, Acute